306748-32-3

Basic information

• Product Name: (6R,7R)-7-{2-(2-tert-Butoxycarbonylamino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-3-(2,6-diamino-pyrimidin-4-ylsulfanylmethylsulfanyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester
• CAS NO: 306748-32-3
• Molecular Weight: 836.01
• Mol File: 306748-32-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (6R,7R)-7-{2-(2-tert-Butoxycarbonylamino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-3-(2,6-diamino-pyrimidin-4-ylsulfanylmethylsulfanyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (6R,7R)-7-{2-(2-tert-Butoxycarbonylamino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-3-(2,6-diamino-pyrimidin-4-ylsulfanylmethylsulfanyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester(306748-32-3)
• EPA Substance Registry System: (6R,7R)-7-{2-(2-tert-Butoxycarbonylamino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-3-(2,6-diamino-pyrimidin-4-ylsulfanylmethylsulfanyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester(306748-32-3)

Safety Data

• Hazardous Substances Data: 306748-32-3(Hazardous Substances Data)

Upstream product

• 56-08-6 2,4-diamino-6-mercaptopyrimidine 
• 136026-50-1 (6R,7R)-3-Acetylsulfanyl-8-oxo-7-phenylacetylamino-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester 
• 73594-89-5 (2-tert-butoxycarbonylamino-thiazol-4-yl)-methoxyimino-acetic acid ethyl ester 
• 73594-90-8 (Z)-2-(2-tert-butoxycarbonylaminothiazol-4-yl)-2-methoxyiminoacetic acid 
• 54639-48-4 (6R,7R)-benzhydryl 3-hydroxy-8-oxo-7-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 

Relevant articles and documents

Synthesis and antibacterial activities of novel C(3)-aminopyrimidinyl substituted cephalosporins including against respiratory tract pathogens

The variety of cephalosporins 1 and 2 which possessed C(3)-aminopyrimidinyl substituents were prepared and evaluated for their antibacterial activities. They exhibited excellent in vitro activities especially against respiratory tract pathogens such as penicillin resistant Streptococcus pneumonia, Moraxella catarrhalis and Haemophilus influenza. (C) 2000 Elsevier Science Ltd.